XUNFEIHEALTH (02506) achieved a revenue of approximately 446 million yuan in the first half of the year, a year-on-year increase of 49.4%.
iFlytek Medical Technology (02506) announced its mid-term results for 2026, with operating income of approximately 446 million yuan, a year-on-year increase of 49.4%; gross profit of approximately 236 million yuan, a year-on-year increase of 53.5%; and a net loss attributable to the owners of the parent company of 59.3 million yuan, narrowing by 20% year-on-year.
XUNFEIHEALTH (02506) announced its mid-year results for 2026, reporting revenue of approximately 446 million yuan, an increase of 49.4% year-on-year; gross profit of approximately 236 million yuan, an increase of 53.5% year-on-year; and a net loss attributable to the owners of the company of 59.303 million yuan, a decrease of 20% year-on-year.
In the first half of 2026, the company actively expanded its market presence, and the client base continued to grow. As of June 30, 2026, the company provided products and services to over 77,000 primary medical institutions, covering 828 districts and counties across 31 provinces, as well as more than 700 graded hospitals. The extensive market coverage fully demonstrates the technological leadership of the company's AI medical products, market competitiveness, and the efficiency of the company's marketing system, laying a solid foundation for the next phase of rapid business development.
To align with the company's medium- and long-term strategic development direction, focus on enhancing quality and efficiency in AI healthcare core businesses, and further optimize resource allocation, the company will integrate and upgrade its original four major business lines into three main business sectors: AI Diagnosis Assistant, AI Health Assistant, and AI Digital Platform. Among them, the "AI Diagnosis Assistant" will take over the original primary care solutions and hospital solutions; the "AI Health Assistant" corresponds to the original patient management service business; and the "AI Digital Platform" corresponds to the original regional solution business.
In the first half of 2026, the company completed the software iteration and upgrade of its core product "Xingyao," officially launching "Xingyao Pro," further optimizing auditory experience and intelligent adaptation capabilities. As of June 30, 2026, the smart hearing aids have established approximately 60 offline brand image stores, with over 400 partnered stores, creating an integrated marketing channel under Wuxi Online Offline Communication Information Technology Co., Ltd., with ongoing enhancements in channel synergy effects.
Related Articles

USAS BUILDING (02671) issued a profit warning, expecting a mid-term consolidated net profit of approximately 9.9 million yuan, a decrease of about 84.2% compared to the same period last year.

ARR operational transformation shows results! iFlytek Medical (02506) reports a 74.9% growth in AI health assistants in the first half of the year, leading the industry, with cloud imaging revenue doubling.

PRECIOUS DRAGON (01861) issued a profit warning, expecting a net loss attributable to shareholders for the interim period not exceeding HKD 16 million, a loss compared to a profit in the same period last year.
USAS BUILDING (02671) issued a profit warning, expecting a mid-term consolidated net profit of approximately 9.9 million yuan, a decrease of about 84.2% compared to the same period last year.

ARR operational transformation shows results! iFlytek Medical (02506) reports a 74.9% growth in AI health assistants in the first half of the year, leading the industry, with cloud imaging revenue doubling.

PRECIOUS DRAGON (01861) issued a profit warning, expecting a net loss attributable to shareholders for the interim period not exceeding HKD 16 million, a loss compared to a profit in the same period last year.

RECOMMEND





